PARP Inhibitors: Usurping DNA Repair to Target Cancer
June 3, 2011|Hematology and Oncology
Author and Disclosure Information
The emerging role for PARP inhibitors in BRCA-mutated cancers is reviewed by Community Oncology Editor-in-Chief Dr. Lee Schwartzberg.
Editor-in-Chief Lee S. Schwartzberg, M.D., is the research medical director at The West Clinic in Memphis, TN.
